A neurologist watches a patient walk down a hallway. No equipment. No sensors. Just observation. She notices the arms barely swing. The steps are short, shuffling, hesitant. The patient hasn't mentioned anything unusual. But the walk already told her something important. That moment — a clinician reading motion before a word is spoken — is where biometric gait recognition and clinical medicine share the same ground. While biometric gait recognition focuses on identifying individuals, clinical gait analysis uses the same sensors and features to understand what is happening inside a person's body, providing insights into their health. Clinical gait analysis evaluates walking as a functional behavior by combining observation with quantitative measurements of movement, timing, forces, and muscle activity. Same signal. Radically different purpose. The main quantitative domains of clinical gait analysis are spatiotemporal measures, kinematics, kinetics, and neuromuscular activity. Think of them as four lenses on the same walk. Spatiotemporal measures capture speed, cadence, step length, stride length, stance time, swing time, and double-support proportion. Kinematics describe joint angles and segment positions. Kinetics describe forces, moments, and power. Electromyography adds muscle-activation timing. Three-dimensional gait analysis can expose dynamic impairments that static imaging simply cannot show, because it measures movement during actual functional walking. Here is a number worth holding onto, Jordan. A walking speed near one meter per second has been reported as a useful approximate marker for risk or decline across several health domains in older adults. Researchers have called gait speed the sixth vital sign. That phrase reflects unusually broad prognostic associations: mobility, cognition, cardiovascular health, falls, and mortality — all linked to one simple measurement. Gait speed is associated with falls, hospitalization, functional decline, and mortality in older adults. Specific conditions leave specific fingerprints. In Parkinson's disease, reduced step and stride length, slower velocity, prolonged stance time, and altered turning can all be quantified — and may track greater clinical severity. [short pause] Gait assessment can reveal information about neurological, musculoskeletal, cardiovascular, metabolic, aging-related, and trauma-related conditions. That means the gait signal is not condition-specific. It is condition-sensitive. A single clinical interpretation should connect a measured deviation to a plausible biomechanical mechanism, not treat any isolated metric as a standalone diagnosis. Now, a counterintuitive point. A less natural walking test can sometimes reveal a disorder more clearly than ordinary hallway walking. Dual-task testing — walking while counting or talking — reduces gait speed and cadence and increases variability compared with walking alone. In one meta-analysis, adding a cognitive task reduced mean walking speed by about 0.19 meters per second. Changes during dual-task testing have been associated with increased future fall risk. Gait asymmetry adds another layer: differences between limbs in step time, stance time, or stride length can be quantified as a percentage. Future fallers showed shorter stride length and higher symmetry cost than non-fallers in longitudinal research. Wearable IMUs enable continuous monitoring in everyday environments, offering valuable data for remote patient monitoring. However, challenges remain in achieving consistent accuracy compared to optical motion capture, particularly for spatiotemporal measures. Inconsistent device placement, limited standardization, and incomplete validation remain real barriers to broad clinical adoption. That means, Jordan, the pipeline matters: defined walking task, calibrated sensing, gait-event detection, feature extraction, quality checks, and interpretation alongside patient history. And the privacy stakes are serious. Gait data can reveal medical conditions before a person has chosen to disclose them. That is a profound ethical boundary. The takeaway is this: while biological gait recognition and clinical gait analysis use similar measurements and sensors, their purposes differ. Clinical analysis focuses on diagnosing and monitoring health conditions, rather than identifying individuals. That overlap is powerful and ethically loaded. Remember: gait can reveal a neurological condition before a patient reports symptoms, and a system that reads identity can simultaneously read health. Any deployment of gait technology in clinical or public settings carries the responsibility to handle that information with the same care a physician owes a patient.